22-19962740-G-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000754.4(COMT):​c.214G>T​(p.Ala72Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00562 in 1,613,680 control chromosomes in the GnomAD database, including 235 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0086 ( 34 hom., cov: 33)
Exomes 𝑓: 0.0053 ( 201 hom. )

Consequence

COMT
NM_000754.4 missense

Scores

4
13

Clinical Significance

Uncertain significance criteria provided, single submitter U:1O:2

Conservation

PhyloP100: 3.56

Publications

108 publications found
Variant links:
Genes affected
COMT (HGNC:2228): (catechol-O-methyltransferase) Catechol-O-methyltransferase catalyzes the transfer of a methyl group from S-adenosylmethionine to catecholamines, including the neurotransmitters dopamine, epinephrine, and norepinephrine. This O-methylation results in one of the major degradative pathways of the catecholamine transmitters. In addition to its role in the metabolism of endogenous substances, COMT is important in the metabolism of catechol drugs used in the treatment of hypertension, asthma, and Parkinson disease. COMT is found in two forms in tissues, a soluble form (S-COMT) and a membrane-bound form (MB-COMT). The differences between S-COMT and MB-COMT reside within the N-termini. Several transcript variants are formed through the use of alternative translation initiation sites and promoters. [provided by RefSeq, Sep 2008]
COMT Gene-Disease associations (from GenCC):
  • paroxysmal dyskinesia
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.002458036).
BA1
GnomAdExome4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0685 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COMTNM_000754.4 linkc.214G>T p.Ala72Ser missense_variant Exon 3 of 6 ENST00000361682.11 NP_000745.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COMTENST00000361682.11 linkc.214G>T p.Ala72Ser missense_variant Exon 3 of 6 1 NM_000754.4 ENSP00000354511.6

Frequencies

GnomAD3 genomes
AF:
0.00867
AC:
1319
AN:
152202
Hom.:
35
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000483
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.0224
Gnomad ASJ
AF:
0.00144
Gnomad EAS
AF:
0.0492
Gnomad SAS
AF:
0.00248
Gnomad FIN
AF:
0.0540
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00140
Gnomad OTH
AF:
0.00669
GnomAD2 exomes
AF:
0.0138
AC:
3468
AN:
250656
AF XY:
0.0119
show subpopulations
Gnomad AFR exome
AF:
0.000803
Gnomad AMR exome
AF:
0.0375
Gnomad ASJ exome
AF:
0.000598
Gnomad EAS exome
AF:
0.0469
Gnomad FIN exome
AF:
0.0480
Gnomad NFE exome
AF:
0.00131
Gnomad OTH exome
AF:
0.00963
GnomAD4 exome
AF:
0.00531
AC:
7753
AN:
1461360
Hom.:
201
Cov.:
35
AF XY:
0.00505
AC XY:
3673
AN XY:
726992
show subpopulations
African (AFR)
AF:
0.000358
AC:
12
AN:
33480
American (AMR)
AF:
0.0375
AC:
1678
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.000536
AC:
14
AN:
26132
East Asian (EAS)
AF:
0.0706
AC:
2804
AN:
39698
South Asian (SAS)
AF:
0.00167
AC:
144
AN:
86256
European-Finnish (FIN)
AF:
0.0436
AC:
2310
AN:
52996
Middle Eastern (MID)
AF:
0.000520
AC:
3
AN:
5768
European-Non Finnish (NFE)
AF:
0.000456
AC:
507
AN:
1111936
Other (OTH)
AF:
0.00465
AC:
281
AN:
60380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
442
884
1325
1767
2209
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
76
152
228
304
380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00863
AC:
1314
AN:
152320
Hom.:
34
Cov.:
33
AF XY:
0.0111
AC XY:
830
AN XY:
74482
show subpopulations
African (AFR)
AF:
0.000481
AC:
20
AN:
41566
American (AMR)
AF:
0.0222
AC:
340
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00144
AC:
5
AN:
3472
East Asian (EAS)
AF:
0.0491
AC:
254
AN:
5174
South Asian (SAS)
AF:
0.00248
AC:
12
AN:
4832
European-Finnish (FIN)
AF:
0.0540
AC:
574
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00140
AC:
95
AN:
68032
Other (OTH)
AF:
0.00615
AC:
13
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
59
119
178
238
297
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00358
Hom.:
43
Bravo
AF:
0.00752
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.000681
AC:
3
ESP6500EA
AF:
0.000930
AC:
8
ExAC
AF:
0.0116
AC:
1408
Asia WGS
AF:
0.0190
AC:
67
AN:
3478
EpiCase
AF:
0.000491
EpiControl
AF:
0.000474

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1Other:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

22q11.2 deletion syndrome Uncertain:1
Oct 10, 2022
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:research

Schizophrenia, susceptibility to Other:1
Mar 01, 2005
OMIM
Significance:risk factor
Review Status:no assertion criteria provided
Collection Method:literature only

Tramadol response Other:1
Apr 28, 2018
Bruce Budowle Laboratory, University of North Texas Health Science Center
Significance:drug response
Review Status:no assertion criteria provided
Collection Method:research

T:M1 = postmortem ratio or tramadol to O-desmethyltramadol; t-MP = model-based clustered metabolizer phenotype inferred from T:M1

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.52
T
BayesDel_noAF
Benign
-0.46
CADD
Benign
19
DANN
Uncertain
0.99
DEOGEN2
Benign
0.12
T;.;T;T;T;T;.
Eigen
Benign
-0.097
Eigen_PC
Benign
-0.12
FATHMM_MKL
Uncertain
0.86
D
LIST_S2
Benign
0.0
.;T;.;.;T;T;T
MetaRNN
Benign
0.0025
T;T;T;T;T;T;T
MetaSVM
Benign
-0.84
T
MutationAssessor
Benign
0.90
L;.;L;L;.;L;.
PhyloP100
3.6
PrimateAI
Benign
0.32
T
PROVEAN
Benign
-0.51
N;N;N;.;N;N;N
REVEL
Benign
0.20
Sift
Uncertain
0.022
D;D;D;.;D;D;D
Sift4G
Uncertain
0.015
D;D;D;D;D;D;D
Vest4
0.10
ClinPred
0.029
T
GERP RS
2.1
PromoterAI
-0.019
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.33
gMVP
0.74
Mutation Taster
=95/5
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6267; hg19: chr22-19950263; COSMIC: COSV52889836; COSMIC: COSV52889836; API